Aliskiren
aliskiren hemifumarate
- Strength
- 300 mg/1
- Form
- Tablet, Film Coated
- Class
- Renin Inhibitor
Prasco Laboratories
Not stocked by us — reference only
Listed by Par Health USA, LLC
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Renin Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 49884-425 |
| FDA application | ANDA206665 |
| RxNorm concept | 1011736 |
| Package sizes listed | 1 |
| Marketed since | March 2019 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
aliskiren hemifumarate
Prasco Laboratories
Not stocked by us — reference only
aliskiren hemifumarate
Prasco Laboratories
Not stocked by us — reference only
Par Health USA, LLC
Not stocked by us — reference only
aliskiren hemifumarate
LXO US Inc.
Not stocked by us — reference only
aliskiren hemifumarate
LXO US Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.